Exhibit (a)(1)(C)
| | | | Acceptance Form for the public cash tender offer by Goldcup 33985 AB (u.c.t. Orion Acquisition AB) to shareholders in Olink Holding AB (publ) Shareholders of Common Shares, ISIN: SE0015797568 |
| | | | |||
Please submit this Acceptance form to: DNB Markets, a part of DNB Bank ASA, Sweden Branch Regeringsgatan 59, 105 88 Stockholm, Sweden DNB Markets, Securities Services at emissioner@dnb.se Phone: +46 8 473 45 50 | | | Acceptance period: Commenced on Oct 31, 2023 and will expire at 6:00 p.m., New York time, on November 30, 2023 Deadline to submit this form: Received by DNB no later than 4:00 p.m., Swedish time, on November 30, 2023 Price per share: USD $26.00 per Olink share Payment date: on or about December 5, 2023 | | |
This acceptance form must be received by DNB Markets no later than 4:00 p.m., Swedish time, on November 30, 2023
The undersigned is aware and acknowledges:
• | Incomplete, wrongly completed, or late acceptance forms might be disregarded by DNB. |
• | This Acceptance Form shall be used by directly registered shareholders and nominees (Sw. förvaltare) |
• | DNB is hereby granted a proxy to take the actions DNB finds necessary to execute this acceptance. |
• | No changes are allowed to the printed text on this form. |
• | The undersigned has read the section Important Information on the second page. |
• | Decision to accept the Offer has not been preceded by investment advice or other advice, the undersigned has independently made the decision to tender the shares. |
• | Information such as securities account (Sw. värdepapperskonto), address and cash bank account details will be collected from Euroclear Sweden AB (“Euroclear”) unless otherwise instructed in writing by the undersigned and accepted by DNB Markets. |
Terms
The undersigned Olink Holding AB (publ) (“Olink”) shareholder, whose common shares, quota value SEK 2.431906612623020 per share (the “Shares”), are directly registered with Euroclear Sweden AB, or a nominee of such a shareholder or shareholders, hereby accepts the Offer (as defined in the Offer to Purchase, dated as of October 31, 2023, as amended and supplemented from time to time) of USD $26.00 per Share in accordance with the terms in the Offer and all published amendments and supplements. The undersigned accepts and acknowledges that Thermo Fisher Scientific Inc, parent company of Goldcup 33985 AB (u.c.t. Orion Acquisition AB), (the “Buyer”), has appointed DNB Markets as its tender agent with respect to the Shares in connection with the Offer. DNB Markets is granted authority to take any reasonable actions needed to execute the acceptance in accordance with the Offering. Furthermore, DNB Markets will be managing the transfer of Shares and wiring of cash consideration.
The initial acceptance period for the Offer (the “Offer Period”) will expire at 6:00 p.m., New York time, on November 30, 2023 (the “Expiration Time”), unless the Offer Period is extended or earlier terminated. The Offer is conditioned upon, among other things, a Regulatory Condition and a Minimum Tender Condition, each as described in Section 1—“Terms of the Offer” of the Offer to Purchase. If any of the conditions to closing (including the Regulatory Condition) is not satisfied as of the Expiration Time, the Offer may be extended as described in more detail in the Offer to Purchase. Should the Buyer extend the Offer it will be done by consecutive periods of ten business days.
Shareholders who wish to accept the Offer (or nominee of such shareholders) and whose Shares are held on a directly registered Euroclear account shall use this Acceptance Form. The Shares tendered into the Offer will be blocked and transferred to a newly opened Euroclear retrieving account (apportkonto), in the name of the shareholder or nominee. Euroclear will send a notification to the shareholder or nominee showing the movement of the Shares that the shareholder tendered into the Offer. Shareholders who hold Shares in the name of a broker, dealer,